Endo Acquires Paladin Labs Inc. - Quick Facts

(RTTNews) - Endo International plc (ENDP), formerly Endo Health Solutions Inc., announced that it has completed the acquisition of Paladin Labs Inc. in a stock and cash transaction currently valued at about $2.7 billion.

The company said that the acquisition accelerates Endo's strategic transformation into a leading global specialty healthcare company and creates a platform for future growth in North America and around the globe.

Under the terms of the transaction, Paladin Labs shareholders received 1.6331 shares of Endo International plc stock and C$1.16 in cash for each Paladin Labs share they owned upon closing. In addition, for each Paladin Labs share owned at closing, shareholders of Paladin Labs received one share of Knight Therapeutics Inc., a newly formed Canadian company that has been separated as part of the transaction.

Shareholders of Endo Health Solutions received one share of Endo International plc for each share of Endo Health Solutions Inc. they owned upon closing.